EMBED 3.0 - Improvement of Formulations

Cardiff University
Direct award
2 November 2026 to 31 December 2026

Formulation improvement work for the EMBED medication-delivery technology, demonstrating the ability to vary additional batches and assess whether they provide a more robust mechanism for medication entry into patients. The work supports progression from EMBED 3.0 towards human trials.

Open the official notice

Awarded value: £188k; As published
Published: 19 October 2026
Awarded: 19 October 2026; ProMed Pharma, LLC
Contract length: 2 months; Ends 31 December 2026

What the contract covers

Direct award

Development and testing of pharmaceutical formulations and drug-delivery technologies, including batch variation to improve medication delivery mechanisms.

Demonstrate their ability to vary the additional batches offer a more robust mechanism for the medications to enter patients
Increase the viability of the delivery method (technology developed as part of EMBED)

Terms and requirements

Contract type: Direct award
Procedure: Direct award
Initial term: 2 months
Contract dates: 2 November 2026 to 31 December 2026
Certifications asked for: None stated
Lots: 1
Suitable for SMEs: Not stated
CPV codes: 73000000

Services in this contract

Aseptic compounding, specials and contract pharmaceutical manufacturingMain service£151k typicalFormulation improvement and additional batches for trial medicine ahead of human trials

Lifecycle

Published
19 October 2026
Contract awardedto ProMed Pharma, LLC
19 October 2026
Contract starts
2 November 2026
Contract ends
31 December 2026

The buyer

Cardiff University

Type: Locked
Contracts, 24 months: Locked
Recorded value: Locked
Typical contract: Locked
Unlicensed medicines contracts, 24 months: Locked

Buys most

Contact details

Email: Locked
Website: Locked
Address: Locked

See everything Cardiff University buys

The supplier

ProMed Pharma, LLC

Contracts won, 24 months: Locked
Value won, 24 months: Locked
Buyers, 24 months: Locked
Size: Locked

Main buyers

See everything ProMed Pharma, LLC has won

Similar unlicensed medicines contracts and prices

31 unlicensed medicines contracts were awarded in the last 24 months. See who won them and what they went for, next to this one.

See who won them →

Cite this contract

Link: https://bidskim.com/tender/3891355/embed-3-0-improvement-of-formulations
Buyer reference: Not published
Open contracting ID: ocds-h6vhtk-078aee
Last checked: 5 November 2026

Cardiff University. EMBED 3.0 - Improvement of Formulations. Contract award, 19 October 2026. BidSkim, https://bidskim.com/tender/3891355/embed-3-0-improvement-of-formulations (accessed 5 November 2026).